Has John Coccaro, MD received payments from drug or device companies?

Yes. Drug and device makers reported $17,116 in general payments to John Coccaro, MD across 449 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Coccaro, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Coccaro, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Coccaro, MD

Interventional Pain Medicine · Toms River, NJNPI 1235280314

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $12,981 of the $17,116 with a category attached, or 75.8%. 24 manufacturers reported payments, led by Nevro Corp. at 28.4% of the total. Reporting peaked in 2019 at $4,825 and has fallen 56.8% since, to $2,084 in 2025. Among interventional pain medicine clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,116in general payments, 2019–2025

Across 449 payments — averaging $38.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Nevro Corp.$5K
Boston Scientific$3K
Medtronic$2K
Saluda Medical Americas, Inc.$2K
Spinal Simplicity, LLC$1K
Vertiflex, Inc.$943
plus $3K from 18 others

What the payments were for

Travel & lodging$3,71422%
Food & beverage$12,98176%
Education$4212%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Nevro Corp.	122	$4,859
Boston Scientific	111	$3,071
Medtronic(2 entities)	43	$2,310
Saluda Medical Americas, Inc.	15	$1,649
Spinal Simplicity, LLC	10	$1,051
Vertiflex, Inc.	6	$943
Vertos Medical, Inc.	13	$756
Abbott	81	$732
Si-bone, Inc.	12	$652
Nalu Medical, Inc.	9	$230
SPR Therapeutics, Inc	3	$167
Globus Medical(2 entities)	3	$129
Biotronik NRO, Inc.	2	$128
Foundation Fusion Solutions, LLC	3	$109
Biodelivery Sciences International, Inc.	6	$80
Providence Medical Technology, Inc.	1	$68
Bioventus LLC	2	$35
Pacira Pharmaceuticals Incorporated	1	$35
Stryker	1	$33
Medline Industries LP	1	$23
Fidia Pharma USA Inc.	1	$17
Johnson & Johnson	1	$16
Teva Pharmaceuticals USA, Inc.	1	$12
Painteq LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Senza$1,174
Senza Spinal Cord Stimulation System$1,155
GENERAL PAIN MANAGEMENT$1,103
Evoke$1,018
Superion ISS$889
INTELLIS$885
HA MINUTEMAN G3-R$799
mild Device Kit$464
Evoke SCS$350
IFUSE IMPLANT SYSTEM$273
INTELLIS ADAPTIVESTIM$263
Omnia$146
MYSTIM$128
WAVEWRITER ALPHA$122
SUPERION$112
Prospera$109
VERTIFLEX SUPERION$109

How this compares

$17,116 in reported general payments places this provider in the 90th percentile of 82 interventional pain medicine providers in New Jersey.

See all interventional pain medicine providers in New Jersey →

Medicare billing

Part B allowed, 2024

$156,620

Medicare patients

160

Services billed

2,054

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	166	$4,538
Fentanyl	12	$3,445
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	130	$3,329
Tramadol Hcl	86	$1,748
Gabapentin	84	$802
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	52	$511
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl	22	$506
Baclofen	29	$431
Acetaminophen-CodeineAcetaminophen With Codeine	15	$265
Hydromorphone Hcl	16	$254
Methadone Hcl	15	$235
Diazepam	12	$29
Clonazepam	11	$25

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Toms River

Michael O HaraToms River$1K
Youssef JosephsonWest Deptford$496K
Ali ValimahomedHolmdel$415K
Saurabh DangEdgewater$157K
Gabriele JasperBrick$114K
Matthew LippChatham$67K
Didier DemesminSomerset$33K
Steve AydinFranklin Lakes$22K
Kieran SlevinHainesport$21K
Dinash YanamadulaLawrenceville$16K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →